United States · FDA National Drug Code directory
Losartan Potassium and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-470_194eea48-8bc8-476d-a604-4b656222d5be
- Product NDC
- 65862-470
- Form
- TABLET, FILM COATED
- Composition / generic term
- Losartan Potassium and Hydrochlorothiazide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101006
- Source listing expiry
- 20261231
Source-listed ingredients
- LOSARTAN POTASSIUM — 100 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (65862-470-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 65862-470-10
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-470-30) · 65862-470-30
- 5000 TABLET, FILM COATED in 1 BOTTLE (65862-470-59) · 65862-470-59
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-470-90) · 65862-470-90
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-470-99) · 65862-470-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →